Luis Báez

857 total citations
22 papers, 654 citations indexed

About

Luis Báez is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luis Báez has authored 22 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luis Báez's work include Cancer Treatment and Pharmacology (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Luis Báez is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Luis Báez collaborates with scholars based in United States, Puerto Rico and El Salvador. Luis Báez's co-authors include David Cella, María Eugenia Jiménez Corona, Gail Shiomoto, Lesbia Hernández, Amy E. Bonomi, Roberta Ortiz, Sandra Luna‐Fineman, Allison Pribnow, James D. Bearden and Michael P. Thirlwell and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Luis Báez

22 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Báez United States 9 340 143 137 129 90 22 654
Ruey‐Kuen Hsieh Taiwan 14 318 0.9× 125 0.9× 188 1.4× 98 0.8× 54 0.6× 48 732
Marlies Peters Netherlands 17 573 1.7× 199 1.4× 111 0.8× 202 1.6× 35 0.4× 33 1.1k
Robin Stuart‐Harris Australia 17 415 1.2× 89 0.6× 130 0.9× 162 1.3× 129 1.4× 32 725
Viswanathan Shanta India 13 227 0.7× 86 0.6× 150 1.1× 70 0.5× 95 1.1× 15 694
J R Daling United States 17 290 0.9× 251 1.8× 250 1.8× 78 0.6× 101 1.1× 30 1.1k
Melissa Accordino United States 18 445 1.3× 77 0.5× 94 0.7× 222 1.7× 112 1.2× 98 905
Volker Ziller Germany 17 421 1.2× 200 1.4× 187 1.4× 65 0.5× 78 0.9× 55 1.1k
Marceli de Oliveira Santos Brazil 14 309 0.9× 210 1.5× 320 2.3× 99 0.8× 39 0.4× 40 789
Fabrizio Artioli Italy 18 497 1.5× 144 1.0× 189 1.4× 358 2.8× 122 1.4× 49 966
Konstantinos Kamposioras Greece 18 570 1.7× 83 0.6× 95 0.7× 193 1.5× 111 1.2× 71 1.0k

Countries citing papers authored by Luis Báez

Since Specialization
Citations

This map shows the geographic impact of Luis Báez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Báez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Báez more than expected).

Fields of papers citing papers by Luis Báez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Báez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Báez. The network helps show where Luis Báez may publish in the future.

Co-authorship network of co-authors of Luis Báez

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Báez. A scholar is included among the top collaborators of Luis Báez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Báez. Luis Báez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luna‐Fineman, Sandra, Mauricio Castellanos, Monika L. Metzger, et al.. (2023). Treatment of high‐risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes. Pediatric Blood & Cancer. 71(2). e30792–e30792. 3 indexed citations
2.
Paz‐Ares, Luis, Edurne Arriola, M.R. García Campelo, et al.. (2021). 1667TiP Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study. Annals of Oncology. 32. S1171–S1172. 2 indexed citations
3.
Redondo, Natalia, et al.. (2019). P1‐544: FREQUENCY OF PERCEIVED NEEDS IN PUERTO RICAN ELDERLY AT SIX MONTHS AND A YEAR AFTER HURRICANE MARIA. Alzheimer s & Dementia. 15(7S_Part_9). 1 indexed citations
4.
Báez, Luis, et al.. (2018). Costo de los accidentes de moto en menores de 19 años atendidos en un hospital de referencia. 45(2). 135–140. 1 indexed citations
5.
Báez, Luis, Armando Peña, Miguel Bonilla, et al.. (2013). A chemotherapy only therapeutic approach to pediatric Hodgkin lymphoma: AHOPCA LH 1999. Pediatric Blood & Cancer. 61(6). 997–1002. 23 indexed citations
6.
Báez, Luis, et al.. (2011). One-dimensional silver nanostructures on single-wall carbon nanotubes. Nanoscale Research Letters. 6(1). 602–602. 3 indexed citations
7.
Bear, Harry D., Gong Tang, Priya Rastogi, et al.. (2011). The effect on pCR of bevacizumab and/or antimetabolites added to standard neoadjuvant chemotherapy: NSABP protocol B-40.. Journal of Clinical Oncology. 29(18_suppl). LBA1005–LBA1005. 33 indexed citations
8.
Fisch, Michael, Ju‐Whei Lee, Judith Manola, et al.. (2009). Survey of disease and treatment-related symptoms in outpatients with invasive cancer of the breast, prostate, lung, or colon/rectum (E2Z02, the SOAPP study). Journal of Clinical Oncology. 27(15_suppl). 9619–9619. 3 indexed citations
9.
Cangiano, José L., Barbara A. Centeno, Christopher R. Garrett, et al.. (2008). Signal Transduction Proteins in Tumors From Puerto Rican and Caucasian Gastric Adenocarcinoma Patients: Expression Differences With Potential for Specific Targeted Therapies. Digestive Diseases and Sciences. 53(8). 2090–2100. 5 indexed citations
10.
Patel, Shreyaskumar, Mary Louise Keohan, Muhammad Wasif Saif, et al.. (2006). Phase II study of intravenous TZT‐1027 in patients with advanced or metastatic soft‐tissue sarcomas with prior exposure to anthracycline‐based chemotherapy. Cancer. 107(12). 2881–2887. 37 indexed citations
11.
12.
Ajani, Jaffer A., Chris H. Takimoto, Carlos Becerra, et al.. (2005). A phase II clinical and pharmacokinetic study of intravenous exatecan mesylate (DX-8951f) in patients with untreated metastatic gastric cancer. Investigational New Drugs. 23(5). 479–484. 20 indexed citations
13.
Millikan, Randall E., et al.. (2001). Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer. Urologic Oncology Seminars and Original Investigations. 6(3). 111–115. 51 indexed citations
14.
Asbury, Robert F., Stuart R. Lipsitz, David L. Graham, et al.. (2000). Treatment of Squamous Cell Esophageal Cancer With Topotecan. American Journal of Clinical Oncology. 23(1). 45–46. 7 indexed citations
15.
Smith, Roy E., Ann Brown, Eleftherios P. Mamounas, et al.. (1999). Randomized Trial of 3-Hour Versus 24-Hour Infusion of High-Dose Paclitaxel in Patients With Metastatic or Locally Advanced Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26. Journal of Clinical Oncology. 17(11). 3403–3411. 129 indexed citations
16.
Cella, David, Lesbia Hernández, Amy E. Bonomi, et al.. (1998). Spanish Language Translation and Initial Validation of the Functional Assessment of Cancer Therapy Quality-of-Life Instrument. Medical Care. 36(9). 1407–1418. 209 indexed citations
17.
Báez, Luis, et al.. (1998). Recent advances in cancer therapy.. PubMed. 89(7-9). 120–6. 1 indexed citations
18.
Huber, Martin H., Scott M. Lippman, Steven E. Benner, et al.. (1995). Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer. Annals of Oncology. 6(1). 83–85. 1 indexed citations
19.
Winn, Rodger J., et al.. (1994). Phase II Study of Merbarone (NSC 336628) in Patients with Advanced Gastric Carcinoma. Cancer Investigation. 12(5). 488–490. 4 indexed citations
20.
Sostre, Samuel, et al.. (1990). Gallium Imaging of Esophageal Carcinoma. Clinical Nuclear Medicine. 15(3). 163–167. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruey‐Kuen Hsieh Breakdown of academic impact, for papers by Marlies Peters Breakdown of academic impact, for papers by Robin Stuart‐Harris Breakdown of academic impact, for papers by Viswanathan Shanta Breakdown of academic impact, for papers by J R Daling Breakdown of academic impact, for papers by Melissa Accordino Breakdown of academic impact, for papers by Volker Ziller Breakdown of academic impact, for papers by Marceli de Oliveira Santos Breakdown of academic impact, for papers by Fabrizio Artioli Breakdown of academic impact, for papers by Konstantinos Kamposioras
Rankless by CCL
2026